Michelle F. Maritz

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Infection risk in myelodysplastic syndromes is dynamic and immune driven.

Infection risk in myelodysplastic syndromes is dynamic and immune driven.

Journal: Blood advances

Published: January 27, 2026

Two-stage inertial microfluidics enrichment of activated T-cells towards a bead-less chimeric antigen receptor manufacturing protocol.

Two-stage inertial microfluidics enrichment of activated T-cells towards a bead-less chimeric antigen receptor manufacturing protocol.

Journal: Medical oncology (Northwood, London, England)

Published: September 07, 2025

Enrichment of T-lymphocytes from leukemic blood using inertial microfluidics toward improved chimeric antigen receptor-T cell manufacturing.

Enrichment of T-lymphocytes from leukemic blood using inertial microfluidics toward improved chimeric antigen receptor-T cell manufacturing.

Journal: Cytotherapy

Published: February 29, 2024

Hydrophobic ion pairing and microfluidic nanoprecipitation enable efficient nanoformulation of a small molecule indolamine 2, 3-dioxygenase inhibitor immunotherapeutic.

Hydrophobic ion pairing and microfluidic nanoprecipitation enable efficient nanoformulation of a small molecule indolamine 2, 3-dioxygenase inhibitor immunotherapeutic.

Journal: Bioengineering & translational medicine

Published: February 22, 2023

Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects.

Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects.

Journal: Journal of nanobiotechnology

Published: November 26, 2022

Glycogen kinase 3 inhibitor nanoformulation as an alternative strategy to inhibit PD-1 immune checkpoint.

Glycogen kinase 3 inhibitor nanoformulation as an alternative strategy to inhibit PD-1 immune checkpoint.

Journal: International journal of pharmaceutics

Published: March 01, 2022

Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation.

Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 04, 2021

High density lipoprotein nanoparticle as delivery system for radio-sensitising miRNA: An investigation in 2D/3D head and neck cancer models.

High density lipoprotein nanoparticle as delivery system for radio-sensitising miRNA: An investigation in 2D/3D head and neck cancer models.

Journal: International journal of pharmaceutics

Published: October 08, 2021

Inertial Microfluidic Purification of CAR-T-Cell Products.

Inertial Microfluidic Purification of CAR-T-Cell Products.

Journal: Advanced biology

Published: May 30, 2021

DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts.

DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts.

Journal: Haematologica

Published: January 04, 2019

Telomerase promotes formation of a telomere protective complex in cancer cells.

Telomerase promotes formation of a telomere protective complex in cancer cells.

Journal: Science advances

Published: September 16, 2018

Ras Transformation Overrides a Proliferation Defect Induced by Tpm3.1 Knockout.

Ras Transformation Overrides a Proliferation Defect Induced by Tpm3.1 Knockout.

Journal: Cellular & molecular biology letters

Published: May 28, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026